Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

Presentation TCT 2024

Current Blueprint of the FDA Diversity Plans

Presenter: Jaime Raben

October 29, 2024

Presentation TCT 2024

What’s Needed from a Patient’s Perspective

Presenter: Rhonda Monroe

October 29, 2024

Presentation TCT 2024

How Can Clinical Trials Mobilize the Diversity Efforts?

Presenter: Roxana Mehran

October 29, 2024

Presentation NY Valves 2024

Diversity and Under Represented Populations in VHD: Focusing on Real Solutions

Presenter: Annetine C. Gelijns, Megan Coylewright

June 06, 2024

Presentation NY Valves 2024

Challenges With Vulnerable, Underrepresented Populations

Presenter: Clyde W. Yancy

June 06, 2024

Presentation NY Valves 2024

Trialist Perspective

Presenter: Roxana Mehran

June 06, 2024

Presentation NY Valves 2024

Industry Perspective

Presenter: Janarthanan Sathananthan

June 06, 2024

Presentation NY Valves 2024

FDA Perspective

Presenter: Lisa Plummer

June 06, 2024

Presentation NY Valves 2024

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Presenter: Guillaume Bonnet

June 05, 2024

Presentation CTO 2024

Geographic Diversity in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry

Presenter: Michaella Alexandrou

February 02, 2024

Presentation TCT 2023

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

Presenter: Eric Secemsky

October 26, 2023

Presentation TCT 2023

Implications for RCTs and Work Force Considerations

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

FDA DEI Initiatives

Presenter: Jaime Raben

October 24, 2023

Presentation THT 2023

The Leaders of the Pack: Why Improving Investigator Diversity in Heart Failure Trials is a Key Priority

Presenter: Eldrin Lewis

March 20, 2023

Presentation THT 2023

Recruitment Strategies for Vulnerable and Marginalized Trial Participants

Presenter: Wayne Batchelor

March 20, 2023

Presentation THT 2023

Training Investigators to Advance Diversity and Inclusion

Presenter: Mariell Jessup

March 20, 2023

Presentation THT 2023

FDA Guidance on Meaningful Representation in Clinical Trials

Presenter: Bram Zuckerman

March 20, 2023

Presentation THT 2023

Now is Not Soon Enough: Why Improving Patient Diversity in HF Trials is a Key Priority

Presenter: Harriette Van Spall

March 20, 2023

Presentation TCT 2022

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

Presenter: Eric Secemsky

September 17, 2022

Presentation THT 2022

How to Improve Diversity in Heart Failure: Patients, Investigators, Trials

Presenter: Alanna Morris

February 01, 2022

Advertisement

Current Blueprint of the FDA Diversity Plans

What’s Needed from a Patient’s Perspective

How Can Clinical Trials Mobilize the Diversity Efforts?

Diversity and Under Represented Populations in VHD: Focusing on Real Solutions

Challenges With Vulnerable, Underrepresented Populations

Trialist Perspective

Industry Perspective

FDA Perspective

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Geographic Diversity in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

Implications for RCTs and Work Force Considerations

FDA DEI Initiatives

The Leaders of the Pack: Why Improving Investigator Diversity in Heart Failure Trials is a Key Priority

Recruitment Strategies for Vulnerable and Marginalized Trial Participants

Training Investigators to Advance Diversity and Inclusion

FDA Guidance on Meaningful Representation in Clinical Trials

Now is Not Soon Enough: Why Improving Patient Diversity in HF Trials is a Key Priority

Increasing Diversity in Peripheral Vascular Disease Research: The Elegance Registry

How to Improve Diversity in Heart Failure: Patients, Investigators, Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content